BEAM
Price
$20.01
Change
+$0.13 (+0.65%)
Updated
Jul 3 closing price
Capitalization
2.01B
37 days until earnings call
CARM
Price
$0.40
Change
-$0.02 (-4.76%)
Updated
Jul 3 closing price
Capitalization
16.84M
Interact to see
Advertisement

BEAM vs CARM

Header iconBEAM vs CARM Comparison
Open Charts BEAM vs CARMBanner chart's image
Beam Therapeutics
Price$20.01
Change+$0.13 (+0.65%)
Volume$1.36M
Capitalization2.01B
Carisma Therapeutics
Price$0.40
Change-$0.02 (-4.76%)
Volume$398.66K
Capitalization16.84M
BEAM vs CARM Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CARM commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and CARM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (BEAM: $20.01 vs. CARM: $0.40)
Brand notoriety: BEAM and CARM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 72% vs. CARM: 2%
Market capitalization -- BEAM: $2.01B vs. CARM: $16.84M
BEAM [@Biotechnology] is valued at $2.01B. CARM’s [@Biotechnology] market capitalization is $16.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCARM’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CARM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than CARM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while CARM’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • CARM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CARM is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +16.74% price change this week, while CARM (@Biotechnology) price change was -0.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

CARM is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.01B) has a higher market cap than CARM($16.8M). CARM YTD gains are higher at: -3.773 vs. BEAM (-19.315). CARM has higher annual earnings (EBITDA): -49.68M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. CARM (7.74M). CARM has less debt than BEAM: CARM (2.33M) vs BEAM (158M). BEAM has higher revenues than CARM: BEAM (63.6M) vs CARM (20M).
BEAMCARMBEAM / CARM
Capitalization2.01B16.8M11,976%
EBITDA-399.03M-49.68M803%
Gain YTD-19.315-3.773512%
P/E RatioN/AN/A-
Revenue63.6M20M318%
Total Cash1.22B7.74M15,762%
Total Debt158M2.33M6,796%
FUNDAMENTALS RATINGS
CARM: Fundamental Ratings
CARM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCARM
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
85%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGBGX49.570.69
+1.41%
Principal Blue Chip R5
PIEFX18.030.15
+0.84%
Federated Hermes Emerging Markets Eq IS
ACUIX38.500.19
+0.50%
Columbia Dividend Opportunity C
IVKIX22.680.11
+0.49%
VY® Invesco Comstock I
AWWIX15.310.01
+0.07%
CIBC Atlas International Growth Instl

CARM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CARM has been loosely correlated with EVGN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CARM jumps, then EVGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARM
1D Price
Change %
CARM100%
-4.05%
EVGN - CARM
58%
Loosely correlated
-1.47%
INSM - CARM
40%
Loosely correlated
N/A
PMVP - CARM
33%
Loosely correlated
+8.18%
ABCL - CARM
31%
Poorly correlated
+1.33%
VCYT - CARM
31%
Poorly correlated
N/A
More